In the study of over 200 patients, 90.1% of those who received TC-325 had their bleeding controlled within 30 days, as compared to 81.4% of those who received standard treatment, meeting criteria for ...

Marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Addressing intraoperative bleeding ...

On modern battlefields and city streets alike, the difference between life and death after a major injury is often measured in seconds. Now researchers say a new sprayable powder can halt catastrophic ...

SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...

Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...

In emergency rooms, trauma centers, and across the medical field, one of the constant enemies for nurses, doctors, and ...

Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed an innovative spray-on, powder-type hemostatic agent that can stop ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc., a privately held medical device company founded by surgeons and biomaterial scientists announces the CE approval of EndoClot ® Adhesive ...

SOMERVILLE, N.J., June 6, 2017 /PRNewswire/ -- Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources. 1-9 Primary methods of hemostasis alone may be ...